News

pharmaceutical drug approval process

Researchers used advanced AI to see if any FDA-approved medications could potentially reverse one of the mutations behind dilated cardiomyopathy. Risedronate, a popular osteoporosis medication, is the one candidate that got the job done.

Biosense Webster, part of Johnson & Johnson MedTech, shared updated data on its Varipulse pulsed field ablation (PFA) system at AF Symposium 2024 in Boston,

Johnson & Johnson MedTech has resumed the U.S. rollout of its Varipulse PFA system, sharing new warnings to help physicians. 

Thumbnail

Military veterans face an increased risk of cardiovascular disease, making it especially important to ensure they receive high-quality care.

lung cancer pulmonary nodule

These findings show that opportunistic imaging could go a long way toward making more patients aware of the cardiovascular risks they face—all without requiring additional scans to be performed. 

AI artificial intelligence stethoscope doctor

It can be challenging to know which AFib patients are the best candidates for LAAO. A new algorithm out of Mayo Clinic aims to address that problem. 

the words "FDA recall" on a board

No devices need to be returned at this time. However, the FDA warned, using these heart pumps without reviewing the updated instructions could result in "serious injury or death.” 

healthcare value value-based care money dollar

Other procedures are associated with higher profits—heart transplants, for instance—but CABG and TAVR are performed much more often.

Heart cardiologists doctors surgery

A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.

healthcare value value-based care money dollar

Other procedures are associated with higher profits—heart transplants, for instance—but CABG and TAVR are performed much more often.

Heart cardiologists doctors surgery

A trio of leading voices in cardiology reviewed years of data while considering their proposal. The choice between TAVR and SAVR, they added, should be made on a case-by-case basis.

Thumbnail

The FDA recently cleared the company's cable-free, credit card-sized heart monitor that produces 12-lead ECGs.

Johnson & Johnson MedTech has launched a new next-generation catheter to be used when treating acute ischemic stroke patients. The Cereglide 92 Catheter System includes a 0.92” catheter as well as the company’s Innerglide 9 deliver aid.

The next-generation catheter was designed to help clinicians restore blood flow safely and effectively after patients have experienced an acute ischemic stroke. 

Around the web

GE HealthCare said the price of iodine contrast increased by more than 200% between 2017 to 2023. Will new Chinese tariffs drive costs even higher?

The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025. 

The team hopes to develop a model that will estimate a patient's risk of major cardiovascular events and predict when such events are most likely to occur.